Drought presents challenges to cotton farmers in West Texas and this past growing season was no exception. But despite periods of moderate to severe drought in the region, some farmers reported higher crop yields after using a microbial treatment that helped... Read more »
Happy new year, everyone. Are you all strapped in? Tray tables in the locked and upright position? As Bette Davis once said, “It’s going to be a bumpy night.”
The news from Washington is already coming fast and furious. The... Read more »
This past Christmas weekend, Ana Memedovich had her best two days in more than a decade.
Her 23-year-old son Mikhail has spinal muscular atrophy, or SMA, a rare genetic disease that has slowly robbed him of the ability to walk and... Read more »
In certain patients who are being treated for cancer, it’s possible for cells to detach from the tumors inside their bodies and begin moving through the bloodstream.
These circulating tumor cells, or CTCs, can help oncologists and other clinicians determine how... Read more »
Seniors in Massachusetts, Indiana, and Pennsylvania, as well as military families across the nation, will soon get the opportunity to test a major healthcare reform developed by faculty at the University of Michigan.
Called Value-Based Insurance Design (V-BID), the new approach... Read more »
[Updated 12/29/16, 2:50 pm. See below.] The FDA has rejected a Cempra antibiotic drug for community-acquired bacterial pneumonia citing the same safety issues that came to light when an independent advisory panel to the regulator evaluated the drug in... Read more »
You’ve probably seen the Internet memes. “When 2016 started, I looked like this. [Insert picture of young Leo DiCaprio.] Now I look like this. [Leo, with mountain beard, after mud-wrestling with a grizzly in The Revenant.]” In life science terms,... Read more »
We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here, with looks at key studies in... Read more »
[Updated, 4:28 pm ET, see below] After years of research, frustration, hype, and millions (sometimes hundreds of millions) of dollars invested, a drug program boils down to the clinical data—usually from big, late-stage studies—that can sometimes make or break... Read more »